This chief scientific officer at Moderna breaks down the misunderstandings about the mRNA in the COVID-19 vaccine, and explains how it could change the world

(via TED Talks)

Today we welcome world leaders in #RNA research and therapeutics to our SAB. We will work with them to harness the power of #tRNA biology to advance a single medicine with the potential to treat thousands of diseases.

Release: bit.ly/3iaFZFG
bit.ly/3i6SfqC

I’m very excited to be part of this new company!

The pace of progress in medicine is moving at record speed. Discover how Nasdaq-100 listed Moderna is accelerating innovation to meet unmet medical needs.

Apparently I’ve been referenced on Saturday Night Live - SNL by Maya Rudolph? I just woke up to a ton of text messages

We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: buff.ly/3puVGK6

We just announced a longer shelf life at refrigerated temperatures for mRNA-1273, our COVID-19 vaccine candidate. Read more: buff.ly/3f2RE6V

Announcing the exciting PROGRAM of the 8th International #mRNA Health Conference​! Comprehensive topics will be presented including a special focus on #COVID19 #vaccines !

mrna-conference.com/program-speake…

Forward-Looking Information and Factors That May Affect Future Results businesswire.com/news/home/2020…

Congratulations Alnylam Pharmaceuticals! A great day for the entire RNA therapeutics community!

Happy Mole Day everyone! images.app.goo.gl/BRNiX9SK611eKG…

Thank you IUBMB!

The perfect piece of #Modernart for #RNADay ⁦Moderna⁩! Long live our polysome!

The perfect wine for a spliceosome enthusiast on #RNADay ! Thanks Harleen Saini! Or should I say Dr. Saini?

dictionary.com/e/kids-redefin…

Hurricane Maria's Death Toll Was Decades In The Making huffingtonpost.com/entry/opinion-…

Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform dlvr.it/Q9QLq3

Moderna #JPM18 450m$ invested in R&D in 2017...
pipeline below: 19 candidates, 10 clinical trials

Moderna to start phase II trial of AstraZeneca-partnered VEGF project “in matter of weeks”, says Stephane Bancel #JPM18

Standing room only for Moderna’s presentation #JPM18